Literature DB >> 22736325

One-cell biopsy significantly improves the outcome of preimplantation genetic diagnosis (PGD) treatment: retrospective analysis of 569 PGD cycles at the Stockholm PGD centre.

K Haapaniemi Kouru1, H Malmgren, M Nordenskjöld, M Fridström, G Csemiczky, E Blennow.   

Abstract

STUDY QUESTION: What are the significant factors that influence the outcome of a PGD treatment? SUMMARY ANSWER: The age of the woman and the number of biopsied cells per embryo are of significant importance for a successful PGD treatment. WHAT IS KNOWN ALREADY: Younger women are more likely to succeed with an IVF treatment. STUDY DESIGN, SIZE, DURATION: Cohort study, retrospective analysis of 569 PGD cycles, 1996-2009. PARTICIPANTS, SETTING,
METHODS: 256 couples and 569 PGD treatments at 'Stockholm PGD centre'. At this centre after 2003, a 1-cell policy was applied, when possible, with respect to the reliability of the diagnostic test and since 2009, 1-cell biopsy policy was also applied for monogenic disorders. MAIN RESULTS AND THE ROLE OF CHANCE: The women under 36 years of age were three times more likely to get pregnant after PGD treatment, P = 0.003 and odds ratio 3.1 [95% confidence interval (CI) 1.5-6.5]. The 1-cell biopsy cycles were twice as likely to result in a pregnancy in comparison with cycles were 2 cells were removed from the embryo, P = 0.0013 and odds ratio 2.55 (95% CI 1.44-4.52). No other factors were found to be significant for the outcome. LIMITATIONS, REASONS FOR CAUTION: Retrospective analysis with 1- and 2-cell biopsies at different times. WIDER IMPLICATIONS OF THE
FINDINGS: The results will have an impact on the implementation of PGD in general, thereby making it possible to significantly improve the treatment outcome.

Entities:  

Mesh:

Year:  2012        PMID: 22736325     DOI: 10.1093/humrep/des235

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  Evaluation of PCR-based preimplantation genetic diagnosis applied to monogenic diseases: a collaborative ESHRE PGD consortium study.

Authors:  Jos Dreesen; Aspasia Destouni; Georgia Kourlaba; Birte Degn; Wulf Christensen Mette; Filipa Carvalho; Celine Moutou; Sioban Sengupta; Seema Dhanjal; Pamela Renwick; Steven Davies; Emmanouel Kanavakis; Gary Harton; Joanne Traeger-Synodinos
Journal:  Eur J Hum Genet       Date:  2013-12-04       Impact factor: 4.246

2.  Eleven healthy live births: a result of simultaneous preimplantation genetic testing of α- and β-double thalassemia and aneuploidy screening.

Authors:  Dongjia Chen; Xiaoting Shen; Changsheng Wu; Yan Xu; Chenhui Ding; Guirong Zhang; Yanwen Xu; Canquan Zhou
Journal:  J Assist Reprod Genet       Date:  2020-03-09       Impact factor: 3.412

3.  Comprehensive chromosome screening and gene expression analysis from the same biopsy in human preimplantation embryos.

Authors:  Diego Marin; Yujue Wang; Xin Tao; Richard T Scott; Nathan R Treff
Journal:  Mol Hum Reprod       Date:  2017-05-01       Impact factor: 4.025

Review 4.  From Prenatal to Preimplantation Genetic Diagnosis of β-Thalassemia. Prevention Model in 8748 Cases: 40 Years of Single Center Experience.

Authors:  Giovanni Monni; Cristina Peddes; Ambra Iuculano; Rosa Maria Ibba
Journal:  J Clin Med       Date:  2018-02-20       Impact factor: 4.241

5.  Successful Pregnancy Following Preimplantation Genetic Diagnosis of Adrenoleukodystrophy by Detection of Mutation on the ABCD1 Gene.

Authors:  Son Trinh The; Sang Trieu Tien; Tam Vu Van; Nhat Nguyen Ngoc; My Tran Ngoc Thao; Khoa Tran Van; Dinh Vu Nhat; Binh Do Nhu
Journal:  Appl Clin Genet       Date:  2021-07-14

6.  Effects of Gender of Reciprocal Chromosomal Translocation on Blastocyst Formation and Pregnancy Outcome in Preimplantation Genetic Testing.

Authors:  Hui Song; Hao Shi; En-Tong Yang; Zhi-Qin Bu; Zi-Qi Jin; Ming-Zhu Huo; Yi-le Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-21       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.